help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Schravendijk, C. F.
Right arrow Articles by Pipeleers, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Schravendijk, C. F.
Right arrow Articles by Pipeleers, D. G.

Endocrinology, Vol 121, 1784-1788, Copyright © 1987 by Endocrine Society


ARTICLES

Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells

CF Van Schravendijk, A Foriers, JL Van den Brande and DG Pipeleers
Department of Metabolism and Endocrinology, Vrije Universiteit Brussel, Belgium.

Purified rat pancreatic islet cells express somatomedin receptors which are identified by their affinity for insulin-like growth factor (IGF)- I, IGF-II, and insulin. Binding of [125I]IGF-I to islet A cells was half-maximally inhibited by 7.10(-10) M IGF-I, while IGF-II, insulin, and proinsulin were respectively 10-, 500-, and 10,000-fold less potent displacers of IGF-I binding. Unrelated hormones such as glucagon or GH did not compete with [125I]IGF-I binding to A cells. The concentration of IGF-I receptors on A cells was estimated at 5000 IGF-I binding sites per cell with affinity constant (Ka) of 2 X 10(9) M-1. Islet B cells were found to exhibit a reversible time- and temperature-dependent binding with [125I]IGF-I. Specificity and affinity of IGF-I binding sites were identical for islet A and B cells. Linear Scatchard plots of competitive binding data on B cells suggest 1 single class of IGF-I receptors in a concentration of 12,000 sites per cell. The presence of high affinity receptors for IGF-I on adult islet A and B cells provides a molecular basis for this growth factor to influence growth, survival, and/or function of these endocrine cell types. Their low affinity for insulin should be considered as a potential mechanism for this hormone to influence, at high concentration, the function of islet A and B cells.


This article has been cited by other articles:


Home page
FASEB J.Home page
S. Uhles, T. Moede, B. Leibiger, P.-O. Berggren, and I. B. Leibiger
Selective gene activation by spatial segregation of insulin receptor B signaling
FASEB J, May 1, 2007; 21(7): 1609 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Fernandez, M. A. Martin, S. Fajardo, D. Bailbe, M. N. Gangnerau, B. Portha, F. Escriva, P. Serradas, and C. Alvarez
Undernutrition does not alter the activation of beta-cell neogenesis and replication in adult rats after partial pancreatectomy
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E913 - E921.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. N. Flier, R. N. Kulkarni, and C. R. Kahn
Evidence for a circulating islet cell growth factor in insulin-resistant states
PNAS, June 7, 2001; (2001) 131192998.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers
Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus
Diabetes, January 1, 2001; 50(1): 1 - 11.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham
Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets
Endocrinology, March 1, 2000; 141(3): 1151 - 1157.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik, and D. J. Hill
Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia
Endocrinology, May 1, 1999; 140(5): 2353 - 2363.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Petrik, E. Arany, T. J. McDonald, and D. J. Hill
Apoptosis in the Pancreatic Islet Cells of the Neonatal Rat Is Associated with a Reduced Expression of Insulin-Like Growth Factor II that May Act as a Survival Factor
Endocrinology, June 1, 1998; 139(6): 2994 - 3004.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Z. Zhao, H. Zhao, J. Teague, W. Fujimoto, and J. A. Beavo
Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B
PNAS, April 1, 1997; 94(7): 3223 - 3228.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. N. Flier, R. N. Kulkarni, and C. R. Kahn
Evidence for a circulating islet cell growth factor in insulin-resistant states
PNAS, June 19, 2001; 98(13): 7475 - 7480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society